Comprehensive genetic and functional analysis of FcγRs in rituximab therapy for autoimmunity reveals a key role for FcγRIIIa on NK cells
View ORCID ProfileJames I Robinson, View ORCID ProfileMd Yuzaiful Md Yusof, Vinny Davies, Dawn Wild, Michael Morgan, John C Taylor, View ORCID ProfileYasser El-Sherbiny, David L Morris, Lu Liu, Andy C Rawstron, View ORCID ProfileMaya H Buch, Darren Plant, Heather J Cordell, John D Isaacs, View ORCID ProfileIan N Bruce, Paul Emery, View ORCID ProfileAnne Barton, View ORCID ProfileTimothy J Vyse, Jennifer H Barrett, View ORCID ProfileEdward M Vital, View ORCID ProfileAnn W Morgan, MASTERPLANS Consortia on behalf of the MATURA
doi: https://doi.org/10.1101/2021.08.25.21262612
James I Robinson
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
Md Yuzaiful Md Yusof
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
Vinny Davies
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
Dawn Wild
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
Michael Morgan
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
2Cancer Research UK Cambridge Institute, University of Cambridge, Robinson Way, Cambridge, UK
John C Taylor
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
Yasser El-Sherbiny
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
3Department of Biosciences, School of Science and Technology, Nottingham Trent University, Nottingham, UK
David L Morris
4Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College
Lu Liu
4Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College
Andy C Rawstron
5Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust
Maya H Buch
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
6Versus Arthritis Centre for Genetics and Genomics, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, the University of Manchester, Manchester, UK and NIHR Manchester BRC, Manchester University NHS Foundation Trust, Manchester, UK
Darren Plant
6Versus Arthritis Centre for Genetics and Genomics, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, the University of Manchester, Manchester, UK and NIHR Manchester BRC, Manchester University NHS Foundation Trust, Manchester, UK
Heather J Cordell
7Population Health Sciences Institute, Newcastle University, Newcastle, UK
John D Isaacs
8Translational and Clinical Research Institute, Newcastle University and Musculoskeletal Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK London, London, UK
Ian N Bruce
6Versus Arthritis Centre for Genetics and Genomics, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, the University of Manchester, Manchester, UK and NIHR Manchester BRC, Manchester University NHS Foundation Trust, Manchester, UK
Paul Emery
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
9NIHR Leeds Medtech and In vitro Diagnostics Co-operative, Leeds Teaching Hospitals NHS Trust, UK
Anne Barton
6Versus Arthritis Centre for Genetics and Genomics, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, the University of Manchester, Manchester, UK and NIHR Manchester BRC, Manchester University NHS Foundation Trust, Manchester, UK
Timothy J Vyse
4Department of Medical and Molecular Genetics, Faculty of Life Sciences and Medicine, King’s College
Jennifer H Barrett
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
Edward M Vital
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
Ann W Morgan
1School of Medicine, University of Leeds, UK and NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals NHS Trust, UK
9NIHR Leeds Medtech and In vitro Diagnostics Co-operative, Leeds Teaching Hospitals NHS Trust, UK
Data Availability
All data associated with this study are available in the main text or the supplementary materials. Anonymised data and statistical codes can be shared and all requests should be made to AWM to ensure all users of the data adhere to the legal requirements and data sharing of personal data. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Posted August 28, 2021.
Comprehensive genetic and functional analysis of FcγRs in rituximab therapy for autoimmunity reveals a key role for FcγRIIIa on NK cells
James I Robinson, Md Yuzaiful Md Yusof, Vinny Davies, Dawn Wild, Michael Morgan, John C Taylor, Yasser El-Sherbiny, David L Morris, Lu Liu, Andy C Rawstron, Maya H Buch, Darren Plant, Heather J Cordell, John D Isaacs, Ian N Bruce, Paul Emery, Anne Barton, Timothy J Vyse, Jennifer H Barrett, Edward M Vital, Ann W Morgan, MASTERPLANS Consortia
medRxiv 2021.08.25.21262612; doi: https://doi.org/10.1101/2021.08.25.21262612
Comprehensive genetic and functional analysis of FcγRs in rituximab therapy for autoimmunity reveals a key role for FcγRIIIa on NK cells
James I Robinson, Md Yuzaiful Md Yusof, Vinny Davies, Dawn Wild, Michael Morgan, John C Taylor, Yasser El-Sherbiny, David L Morris, Lu Liu, Andy C Rawstron, Maya H Buch, Darren Plant, Heather J Cordell, John D Isaacs, Ian N Bruce, Paul Emery, Anne Barton, Timothy J Vyse, Jennifer H Barrett, Edward M Vital, Ann W Morgan, MASTERPLANS Consortia
medRxiv 2021.08.25.21262612; doi: https://doi.org/10.1101/2021.08.25.21262612
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)